17-8312437-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_173728.4(ARHGEF15):​c.398C>T​(p.Pro133Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00221 in 1,613,806 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P133H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0018 ( 0 hom., cov: 30)
Exomes 𝑓: 0.0023 ( 16 hom. )

Consequence

ARHGEF15
NM_173728.4 missense

Scores

2
17

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.43

Publications

8 publications found
Variant links:
Genes affected
ARHGEF15 (HGNC:15590): (Rho guanine nucleotide exchange factor 15) Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein-coupled receptors. This gene encodes a protein that functions as a specific guanine nucleotide exchange factor for RhoA. It also interacts with ephrin A4 in vascular smooth muscle cells. Two alternatively spliced transcripts variants that encode the same protein have been found for this gene. [provided by RefSeq, Aug 2010]
ARHGEF15 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • schizophrenia
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0050942004).
BP6
Variant 17-8312437-C-T is Benign according to our data. Variant chr17-8312437-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 412673.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 270 Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARHGEF15NM_173728.4 linkc.398C>T p.Pro133Leu missense_variant Exon 2 of 16 ENST00000361926.8 NP_776089.2 O94989A0A0S2Z547

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARHGEF15ENST00000361926.8 linkc.398C>T p.Pro133Leu missense_variant Exon 2 of 16 1 NM_173728.4 ENSP00000355026.3 O94989

Frequencies

GnomAD3 genomes
AF:
0.00177
AC:
270
AN:
152120
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00311
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00348
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00186
AC:
467
AN:
250528
AF XY:
0.00205
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.000550
Gnomad ASJ exome
AF:
0.0000995
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000511
Gnomad NFE exome
AF:
0.00294
Gnomad OTH exome
AF:
0.000818
GnomAD4 exome
AF:
0.00225
AC:
3290
AN:
1461568
Hom.:
16
Cov.:
36
AF XY:
0.00233
AC XY:
1691
AN XY:
727090
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33480
American (AMR)
AF:
0.000693
AC:
31
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0000765
AC:
2
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00326
AC:
281
AN:
86248
European-Finnish (FIN)
AF:
0.000638
AC:
34
AN:
53278
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5764
European-Non Finnish (NFE)
AF:
0.00256
AC:
2844
AN:
1111876
Other (OTH)
AF:
0.00134
AC:
81
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
217
433
650
866
1083
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
94
188
282
376
470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00177
AC:
270
AN:
152238
Hom.:
0
Cov.:
30
AF XY:
0.00169
AC XY:
126
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.000289
AC:
12
AN:
41552
American (AMR)
AF:
0.000262
AC:
4
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5152
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4824
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00348
AC:
237
AN:
68014
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00253
Hom.:
3
Bravo
AF:
0.00150
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00337
AC:
29
ExAC
AF:
0.00206
AC:
250
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00305
EpiControl
AF:
0.00326

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy Benign:1
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ARHGEF15-related disorder Benign:1
Jan 31, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
20
DANN
Benign
0.47
DEOGEN2
Benign
0.16
T;.;T
Eigen
Benign
-0.66
Eigen_PC
Benign
-0.72
FATHMM_MKL
Benign
0.071
N
LIST_S2
Benign
0.56
.;T;T
M_CAP
Benign
0.062
D
MetaRNN
Benign
0.0051
T;T;T
MetaSVM
Benign
-0.74
T
MutationAssessor
Benign
1.1
L;.;L
PhyloP100
1.4
PrimateAI
Benign
0.39
T
PROVEAN
Uncertain
-3.0
D;.;D
REVEL
Benign
0.096
Sift
Benign
0.075
T;.;T
Sift4G
Uncertain
0.0050
D;D;D
Polyphen
0.39
B;.;B
Vest4
0.36
MVP
0.79
MPC
0.26
ClinPred
0.020
T
GERP RS
2.4
Varity_R
0.047
gMVP
0.31
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115065009; hg19: chr17-8215755; COSMIC: COSV62725499; COSMIC: COSV62725499; API